DSS, Inc.'s Form 4 filing
Impact Biomedical Inc. (IBO) · filed Mar 24, 2025
- Accession no.
- 0001641172-25-000403
- Filed
- Mar 24, 2025
- Trade date
- Dec 2, 2024-Mar 20, 2025
- Filing delay
- 112 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $310. Open-market sales total $249.4K. It was filed 112 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DSS, Inc.CIK 0000771999 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Common Stock | SSaleDisposed | −20 | $2.90 | −$58 | 53,080 | Indirect | |
| Mar 20, 2025 | Common Stock | PPurchaseAcquired | +200 | $1.55 | +$310 | 53,280 | Indirect | |
| Mar 20, 2025 | Common Stock | SSaleDisposed | −53,280 | $4.68 | −$249,350.4 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.